Suchergebnisse - "Yang, James Chih-Hsin"

PubPharm (311)

1

RESILIENT Part 2 : A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Spigel, D. | Dowlati, A. | Chen, Y. | +115

2

Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors : Final Results of CheckMate 722

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Mok, T. | Nakagawa, K. | Park, K. | +20

3

Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION

enthalten in: British journal of cancer | 2024

von Kato, T. | Yang, J. | Ahn, M. | +14

4

CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Jänne, P. | Planchard, D. | Kobayashi, K. | +22

5

Re-inventing a better wheel? Serplulimab for squamous cell lung cancer

enthalten in: Cancer cell | 2024

von Huang, D. | Yang, J.

CommentOn: Cancer Cell. 2024 Feb 12;42(2):198-208.e3. - PMID 38181795

6

Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC : Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Reck, M. | Barlesi, F. | Yang, J. | +15

7

Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

enthalten in: Oncology | 2024

von Huang, D. | Liao, B. | Hsu, W. | +12

8

Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer : Results From the CANOPY-A Double-Blind, Randomized Clinical Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Garon, E. | Lu, S. | Goto, Y. | +16

9

Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first‐line EGFR inhibitor resistance in lung cancer

enthalten in: Cancer Medicine | 2024

von Lin, Y. | Ho, C. | Hsu, W. | +11

10

Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007) : A Randomized, Double-Blind, Phase 3 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Yang, J. | Han, B. | De La Mora Jiménez, E. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]